[ad_1] How Erenumab works Erenumab is a human IgG2 antibody that targets the CGRP receptor (peptides bound to the calcitonin gene). This defines the antibody is on a completely new approach in …
Read More »The anti-migraine antibody erenumab is approved in the EU
